Compare Colgate-Palmolive Company (CL) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs Rocket Lab USA Inc — how do they compare? Colgate-Palmolive Company trades at $92.57 (market cap $73.59B), while Rocket Lab USA Inc trades at $80.2 (market cap $50.01B). The key difference: Colgate-Palmolive Company is the larger of the two by market cap, and Colgate-Palmolive Company pays a 2.3% dividend while Rocket Lab USA Inc pays none. Which is the better fit depends on your goals.
| CL | RKLB | |
|---|---|---|
Market Cap | $73.59B | $50.01B |
Sector | Consumer Staples | Technology |
52-Week High | $99.14 | $150.23 |
52-Week Low | $74.98 | $39.48 |
Enterprise Value | $80.07B | $47.84B |
Dividend Yield | 2.3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $93.15, down 0.13% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q2 2026 EPS of $0.99, beating estimates, with 4.9% sales growth driven by emerging markets. However, North American weakness persists, and valuation ratios like P/E of 36.34 and P/B of 311.81 appear elevated. Cash flow remains positive, and a dividend of $0.53 is scheduled for August 2026.
Outlook is mixed: strong brand presence and dividend sustainability support the stock, but high valuation and domestic challenges pose risks. Analyst consensus price target is $99.10, implying modest upside, with 42% buy ratings. Key risks include competitive pressures and margin compression from inflation.
Rocket Lab (RKLB) trades at $81.06, up 1.27% today, with a bullish technical signal from moving averages and a record $2.36 billion backlog supporting growth. Revenue grew 60% year-over-year in Q2 2026, though net losses persist, and the stock is expensive with a P/S ratio of 60.8. Recent news highlights Neutron rocket development delays but strong contract wins.
The outlook is mixed: analyst consensus is bullish with a $118 price target, but profitability remains elusive until 2027. Key risks include execution on Neutron launches, high valuation, and cash burn. Upside depends on successful scaling and margin improvement from government contracts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
